参考文献/References:
[1] Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism[J]. Cell,1986,47(6):921-928.
[2] Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases[J]. N Engl J Med,1997,336(15):1066-1071.
[3] Haudek SB, Bryant DD, Giroir BP. Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure[J]. J Mol Cell Cardiol,2001,33(6):1263-1271.
[4] Lawrence T, Gilroy DW, Colville-Nash PR, et al. Possible new role for NF-kappaB in the resolution of inflammation[J]. Nat Med,2001,7(12):1291-1297.
[5] Wakatsuki S, Suzuki J, Ogawa M, et al. A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration[J]. Expert Opin Ther Targets,2008,12(12):1469-1476.
[6] Yamashita C, Hayashi T, Mori T, et al. Angiotensin Ⅱ receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice[J]. Hypertens Res,2007,30(12):1219-1230.
[7] Wong SC, Fukuchi M, Melnyk P, et al. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure[J]. Circulation,1998,98(2):100-103.
[8] 刘芬,马依彤,杨毅宁,等.小鼠慢性压力后负荷心肌肥厚过程中细胞因子的变化[C].北京:亚洲实验动物学会联合会(AFLAS)第三次会议暨中国实验动物学会(CALAS)第八届学术年会论文集,2008.
[9] 李春跃,王文礼,薛明明,等.压力超负荷性心肌肥厚形成过程中细胞因子TNF-α、IL-1β和IL-6的变化[J].中国现代医学杂志,2006,24:3736-3738.
[10] Okazaki Y, Sawada T, Nagatani K, et al. Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis[J]. J Rheumatol,2005,32(8):1440-1447.
[11] Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis[J]. N Engl J Med,1994,331(19):1286-1292.
[12] Bujak M, Ren G, Kweon HJ, et al. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling[J]. Circulation,2007,116(19):2127-2138.
[13] Ma Y, Chen B, Liu D, et al. MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-kappaB/TGFbeta1 pathway[J]. Biochem Pharmacol,2011,81(10):1228-1236.
[14] Wei LH, Huang XR, Zhang Y, et al. Smad7 inhibits angiotensin Ⅱ-induced hypertensive cardiac remodelling[J]. Cardiovasc Res,2013,99(4):665-673.
[15] Kawamura N, Kubota T, Kawano S, et al. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy[J]. Cardiovasc Res, 2005,66(3):520-529.
[16] Takenaka H, Kihara Y, Iwanaga Y, et al. Angiotensin Ⅱ, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension[J]. J Mol Cell Cardiol,2006,41(6):989-997.
[17] Essick EE, Ouchi N, Wilson RM, et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling[J]. Am J Physiol Heart Circ Physiol,2011,301(3):H984-H993.
[18] Takemoto Y, Yoshiyama M, Takeuchi K, et al. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling[J]. J Mol Cell Cardiol,1999,31(11):2017-2030.
[19] Reddy VS, Prabhu SD, Mummidi S, et al. Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation[J]. Am J Physiol Heart Circ Physiol,2010,299(4):H1242-H1254.
[20] Kawano S, Kubota T, Monden Y, et al. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin Ⅱ[J]. Cardiovasc Res,2005,67(4):689-698.
[21] Thalhamer T, Mcgrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation[J]. Rheumatology(Oxford),2008,47(4):409-414.
[22] Fraccarollo D, Berger S, Galuppo P, et al. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction[J]. Circulation,2011,123(4):400-408.
[23] Verma SK, Krishnamurthy P, Barefield D, et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB[J]. Circulation,2012,126(4):418-429.
[24] Adluri RS, Thirunavukkarasu M, Zhan L, et al. Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction[J]. PLoS One, 2012, 7(3): e34790.
[25] Xing Y, Niu T, Wang W, et al. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2[J]. PLoS One,2012,7(9):e44899.
[26] Gao L, Man GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling[J]. Cardiovasc Res,2009,82(1):9-20.
[27] Bar-Shai M, Carmeli E, Ljubuncic P, et al. Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-kappaB activation[J]. Free Radic Biol Med,2008,44(2):202-214.
[28] Zhu H, Itoh K, Yamamoto M, et al. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury[J]. FEBS Lett,2005,579(14):3029-3036.
[29] Shen G, Jeong WS, Hu R, et al. Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents[J]. Antioxid Redox Signal,2005,7(11-12):1648-1663.
[30] 李慧.NF-κB通路负调控Keap1-Nrf2通路及其分子机制研究[D].天津:天津大学,2009.
[31] Cheung KL, Kong AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention[J]. AAPS J,2010,12(1):87-97.
[32] Jayasooriya RG, Lee KT, Lee HJ, et al. Anti-inflammatory effects of beta-hydroxyisovalerylshikonin in BV2 microglia are mediated through suppression of the PI3K/Akt/NF-κB pathway and activation of the Nrf2/HO-1 pathway[J]. Food Chem Toxicol,2014,65:82-89.
[33] Frantz S, Hu K, Bayer B, et al. Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction[J]. FASEB J,2006,20(11):1918-1920.
[34] Kanters E, Pasparakis M, Gijbels MJ, et al. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice[J]. J Clin Invest,2003,112(8):1176-1185.
[35] Trescher K, Bernecker O, Fellner B, et al. Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart[J]. Eur J Cardiothorac Surg,2004,26(5):960-967.